Hypertension - High Blood Pressure News: Breaking Hypertension - High Blood Pressure News, Comments and Articles. - Page: 4

Researchers rewrite obsolete blood-ordering rules

Johns Hopkins researchers have developed new guidelines—the first in more than 35 years—to govern the amount of blood ordered for surgical patients. The recommendations, based on a lengthy study of blood use at The Johns Hopkins Hospital (JHH), c...

Ariad's Cancer Drug Iclusig Extends The Gleevec Magic

By Peter Geschek:Today, patients with CML (chronic myeloid leukemia) who take Novartis' (NVS) drug Gleevec and follow it up with the newer medications, are projected to survive an average of 30 years, says Dr Brian Druker, the genius inventor behind both Gleevec and Iclusig.This is a far cry from the three- to five-year prognosis that was standard when Druker began practicing medicine in the 1980s...

New Malaria Test Kit Boosts Elimination Efforts Worldwide

New Malaria Test Kit Boosts Elimination Efforts Worldwide A new, highly sensitive blood test that quickly detects even the lowest levels of malaria parasites in the body could make a dramatic difference in efforts to tackle the disease in the UK and across the world, according to new research published in the Journal of Infectious Diseases. In two

Welch Allyn Technology Provides Connectivity Between Diagnostic Devices and EMR

Electronic vital signs documentation results in more immediate and accurate patient data, improved workflow and satisfaction Welch Allyn, a leading medical diagnostic device company that specializes in helping clinicians improve patient outcomes, has been working with Epic to connect several of its vital signs devices, monitors and ECG units to...

New Data Demonstrate Significant And Sustained Blood Pressure Reduction With Boston Scientific Vessix™ Renal Denervation System

PARIS, May 22, 2013 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today reported interim data from the REDUCE-HTN clinical program, which demonstrated a significant and sustained reduction in the blood pressure of patients treated with the Vessix™ Renal Denervation System.  Data on the first 41 subjects enrolled in the REDUCE-HTN clinical program were presented today at...

BioVentrix to Exhibit Revivent™ System, which Surpasses Survival Benefit Threshold for Heart Failure Treatment, at European Heart Failure Congress

NIH-sponsored Trial Linked Reducing Left-sided Heart Volume to Improved Survival for Later-Stage Heart Failure Patients BioVentrix, pioneer of the Less Invasive Ventricular Enhancement™ (LIVE™) procedure for the treatment of heart failure (HF), announced today that it will showcase its Revivent™ Myocardial Anchoring System at the European Heart F...

Scanadu Packs More Features Into Scanadu Scout™; Unveils Design For ScanaFlo™

Company Launches Indiegogo Campaign to Begin Building the Future Global Body of Health Data NASA Ames Research Park, Moffett Field -- Scanadu, a personalized health electronics company participating in the Qualcomm Tricorder X PRIZE, today announced it is one step closer to bringing the first medical tricorder™ to life. In addition to unveiling updat...

PreDiabetes Centers to Appear at the Philadelphia Tour de Cure

King of Prussia Prediabetes Treatment Center Will Attend American Diabetes Association Cycling Event. King of Prussia, PA (PRWEB) May 22, 2013 The PreDiabetes Center of King of Prussia is proud to announce its participation in the Greater Philadelphia Tour de Cure, a premier cycling event that brings together experienced cyclists and recreational riders who are passionate about stopping the sprea...

Cold weather may increase blood pressure

'Bad weather could raise your blood pressure and even kill you,' is the unnecessarily alarmist headline in the Daily Mail. It reports on a large, complex study that looked for any association between changes in weather and blood pressure rates. The research focused on patients at a blood pressure clinic in Glasgow and looked at two consecutive visits the patients made within a 12-month period. Th...

First Edition: May 22, 2013

Today's headlines include reports about how the Medicaid expansion is shaking out in Virginia and Texas, as well as a report about the role health care is playing as the House attempts to negotiate an immigration reform measure.    Kaiser Health News: Capsules: Survey: Even In Southern States, Medicaid Expansion Is Popular; Accuracy of Blood Glucose Meters Draws Scrutiny N...

Perosphere Receives FDA IND Clearance to Initiate Clinical Investigations of the Safety and Efficacy of PER977 to Reverse the Activity of Anticoagulation Therapies including Factor Xa- and IIa-Inhibitors

Clearance also includes Clinical Investigation of PER977 to Reverse the Anticoagulation Activity of Unfractionated Heparin, Low Molecular Weight Heparins, and Fondaparinux Perosphere Inc. announced today that it has received U.S. Food and Drug Administration ("FDA") Investigational New Drug ("IND") clearance to initiate clinical investigations of the s...

Americord Introduces New Logo And Tagline

NEW YORK, May 22, 2013 /PRNewswire/ -- Americord Registry announced today the launch of its new logo and tagline. Both were designed to better convey the company's commitment to making cord blood banking easy to understand and even easier to do. (Logo: http://photos.prnewswire.com/prnh/20130522/NY18754LOGO) The logomark design is a circle with six color bars, each of which has a white dot...

Roche presents new, fully automated lab solution at Europe’s largest diagnostics conference

System improves efficiency and speed of blood sample testing in medical labs...

Corgenix Announces Diagnostic Development Agreement with Lilly

-- Companies to focus on potential companion diagnostic opportunity -- Corgenix Medical Corporation (OTCBB: CONX), a worldwide developer and marketer of diagnostic test kits, announced today that it has entered into a collaboration agreement with Eli Lilly and Company (NYSE: LLY) to develop diagnostic technology in support of a Lilly oncology pipeline...

Study Confirms Dr. Peter J. D'Adamo's Lectin Research

BRIDGEPORT, Conn., May 22, 2013 /PRNewswire/ -- A study presented at the American Heart Association's 2013 Scientific Session found that a diet high in lectins, a carbohydrate binding protein, can be detrimental to your health.  Lectins are commonly found in grains, legumes, tomatoes, and vegetables belonging to the nightshade family.  The research found that the lectins in these "h...

Upsher-Smith Successfully Completes Phase III Study Of USL255 (Extended-Release Topiramate) For Adjunctive Treatment Of Epilepsy In Patients With Refractory Partial-Onset Seizures

MAPLE GROVE, Minn., May 22, 2013 /PRNewswire/ -- Upsher-Smith Laboratories, Inc. today announced the successful completion of its global Phase III clinical trial for USL255 (extended-release topiramate), an internally developed program for the management of epilepsy in adults, using the company's proprietary formulation technology.  USL255 is specifically engineered to provide convenient...

Par Pharmaceutical Begins Shipment of Generic Atacand®

WOODCLIFF LAKE, N.J., May 22, 2013 /PRNewswire/ -- Par Pharmaceutical Companies, Inc. today announced that it has entered into an exclusive U.S. supply and distribution agreement with AstraZeneca to distribute the authorized generic version of AstraZeneca's Atacand® (candesartan cilexetil).  Par has begun shipping 4 mg, 8 mg, 16 mg and 32 mg strengths of candesartan cilexetil tablets.
...

Facing the chill wind of blood pressure

(Medical Xpress)—High blood pressure is something that has traditionally been a problem in Scotland, but might there be a link to our climate?

Pradaxa Lawsuit Draws More Potential Plaintiffs

Prominent law firm D. Miller & Associates seeing more people come forward to participate in lawsuit against the drug’s maker. Houston, Texas (PRWEB) May 22, 2013 D. Miller & Associates, PLLC have announced they are continuing to accept clients for inclusion in a legal action seeking damages from the maker of the blood thinner Pradaxa. Targeted in the Pradaxa lawsuit is German drug maker...

Biomarkers for early malaria diagnosis

Scientists in Japan have developed a technique that could be used to diagnose malaria using a blood plasma sample just one day after infection. It is vital to diagnose malaria as soon as possible to maximise the effectiveness of treatment. Currently,...

Superglue for cells

Scientists in Canada have developed a super-strong membrane adhesive that can stick red blood cells together. The polymer, which is based on the phospholipid head group phosphatidyl choline, could be used to secure cells in particular positions for t...

Phthalates -- chemicals widely found in plastics and processed food -- linked to elevated blood pressure in children and teens

Plastic additives known as phthalates are odorless, colorless and just about everywhere: They turn up in flooring, plastic cups, beach balls, plastic wrap, intravenous tubing and the bodies of most Americans. Once perceived as harmless, phthalates ha...

Lindsley F. Kimball Research Institute receives grant for global health and development research project

The Lindsley F. Kimball Research Institute of the New York Blood Center announced today that it is a Grand Challenges Explorations winner, an initiative funded by the Bill & Melinda Gates Foundation.

Beta-blockers may boost chemo effect in childhood cancer

Beta-blockers, normally used for high blood pressure, could enhance the effectiveness of chemotherapies in treating neuroblastoma, a type of children's cancer, according to a new study published in the British Journal of Cancer, today (Wednesday).

Targeting the X-factor to tackle cardiovascular disease

New research at The University of Nottingham aimed at preventing harmful blood clots associated with heart disease and stroke has recently received a major funding boost from the British Heart Foundation.